Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The history of pharmacovigilance goes back to more than 40 years. The global interest in the monitoring of drug safety showed a remarkable increase in the last four decades especially after the thalidomide disaster in the sixties. The thalidomide disaster opened up the issue of drug safety for the public and healthcare professionals alike and brought about an awareness of the importance of the systemic surveillance “Pharmacovigilance” which focuses on numerous activities which are exclusively intended to improve patient care, and avoidance of ADR or any other drug-related problem (DRP).